Marine Organisms Reveal New Anticancer Molecule with Drug Design Potential
Researchers have identified a novel anticancer molecule, jorumycidine, derived from the symbiotic relationship between a sea slug and its sponge prey. This discovery, published in the journal Communications Chemistry, highlights the potential of marine chemistry in developing stable anticancer drug scaffolds. Jorumycidine, a bis-tetrahydroisoquinoline alkaloid, features a unique hexacyclic structure with an additional oxazolidine ring, distinguishing it from previously known compounds. The study involved collecting specimens from Koh Tao Island, Thailand, and using advanced techniques like nuclear magnetic resonance spectroscopy and high-resolution mass spectrometry to characterize the compounds. The research demonstrated jorumycidine's strong anticancer effects, particularly against multiple myeloma cells, with a half-maximal inhibitory concentration of 13.8 nanomolar. 
